New Insights into the Biology of Renal Cell Carcinoma

被引：56
作者：
Li, Lianjie [1 ,2 ,3 ]
Kaelin, William G., Jr. [1 ,2 ,3 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[2] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA
[3] Brigham & Womens Hosp, Boston, MA 02215 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2011年 / 25卷 / 04期
关键词：
Renal cell carcinoma; Clear-cell renal carcinoma; Hypoxia-inducible factor; HIF-responsive gene products; HYPOXIA-INDUCIBLE FACTOR; HIPPEL-LINDAU GENE; TUMOR-SUPPRESSOR PROTEIN; GROWTH-FACTOR RECEPTOR; HEPATOCYTE GROWTH; PRIMARY CILIUM; UP-REGULATION; MESENCHYMAL TRANSITION; HISTONE DEMETHYLASES; MONOCLONAL-ANTIBODY;
D O I：
10.1016/j.hoc.2011.04.004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ninety percent or more of kidney cancers are believed to be of epithelial cell origin, and are referred to as renal cell carcinoma (RCC), which are further subdivided based on histology into clear-cell RCC (75%), papillary RCC (15%), chromophobe tumor (5%), and oncocytoma (5%). Some genes confer an increased risk of these various histologic RCC subtypes. In practice, there is some overlap among the histologic subtypes, and there are some shared molecular features among these tumor types. This review focuses primarily on the most common form of RCC, clear-cell renal carcinoma, noting some recent advances in the other histologic subtypes.
引用
收藏
页码：667 / +
页数：21
相关论文
共 159 条
[11]   The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIF [J].
Beyer, Sophie ;
Kristensen, Malene Maag ;
Jensen, Kim Steen ;
Johansen, Jens Vilstrup ;
Staller, Peter .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (52) :36542-36552
[12]  
Bindra RS, 2002, CANCER RES, V62, P3014
[13]   Effects of HIF-1 alpha and HIF2 alpha on Growth andMetabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts [J].
Biswas, Swethajit ;
Troy, Helen ;
Leek, Russell ;
Chung, Yuen-Li ;
Li, Ji-liang ;
Raval, Raju R. ;
Turley, Helen ;
Gatter, Kevin ;
Pezzella, Francesco ;
Griffiths, John R. ;
Stubbs, Marion ;
Harris, Adrian L. .
JOURNAL OF ONCOLOGY, 2010, 2010
[14]   Kinase requirements in human cells: III. Altered kinase requirements in VHL-/- cancer cells detected in a pilot synthetic lethal screen [J].
Bommi-Reddy, Archana ;
Almeciga, Ingrid ;
Sawyer, Jacqueline ;
Geisen, Christoph ;
Li, Wenliang ;
Harlow, Ed ;
Kaelin, William G., Jr. ;
Grueneberg, Dorre A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (43) :16484-16489
[15]   Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes [J].
Brugarolas, J ;
Kaelin, WG .
CANCER CELL, 2004, 6 (01) :7-10
[16]  
Bukowski RM, 2007, J CLIN ONCOL, V25, P4536, DOI 10.1200/JCO.2007.11.5154
[17]   Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors [J].
Casanovas, O ;
Hicklin, DJ ;
Bergers, G ;
Hanahan, D .
CANCER CELL, 2005, 8 (04) :299-309
[18]   Endothelial function of von Hippel-Lindau tumor suppressor gene: Control of fibroblast growth factor receptor signaling [J].
Champion, Kristen J. ;
Guinea, Maria ;
Dammai, Vincent ;
Hsu, Tien .
CANCER RESEARCH, 2008, 68 (12) :4649-4657
[19]   Jade-1 inhibits Wnt signalling by ubiquitylating β-catenin and mediates Wnt pathway inhibition by pVHL [J].
Chitalia, Vipul C. ;
Foy, Rebecca L. ;
Bachschmid, Markus M. ;
Zeng, Liling ;
Panchenko, Maria V. ;
Zhou, Mina I. ;
Bharti, Ajit ;
Seldin, David C. ;
Lecker, Stewart H. ;
Dominguez, Isabel ;
Cohen, Herbert T. .
NATURE CELL BIOLOGY, 2008, 10 (10) :1208-1216
[20]   The Efficacy of the Novel Dual PI3-Kinase/mTOR Inhibitor NVP-BEZ235 Compared with Rapamycin in Renal Cell Carcinoma (Publication with Expression of Concern. See vol. 25, pg. 4194, 2019) [J].
Cho, Daniel C. ;
Cohen, Matthew B. ;
Panka, David J. ;
Collins, Michael ;
Ghebremichael, Musie ;
Atkins, Michael B. ;
Signoretti, Sabina ;
Mier, James W. .
CLINICAL CANCER RESEARCH, 2010, 16 (14) :3628-3638
12345678910